• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    There are disclosed a method for assaying antigens or antibodies in the reaction medium, characterized in that a sample containing antigens or antibodies to be assayed is treated with a polyanion which is soluble in the reaction medium and thus treated sample is used for the antigen-antibody reaction; and a reagent for assaying an antigen-antibody reaction, which contains a polyanion and a reaction medium.
    公开号:SU1554782A3
    申请号:SU823430145
    申请日:1982-05-03
    公开日:1990-03-30
    发明作者:Тсутсуй Сатоси；Судо Тадамитсу；Ито Митио
    申请人:Мицубиси Касеи Корпорейшн (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to methods for determining antigens or antibodies in a biological fluid.
    The purpose of the invention is to improve the accuracy of the method.
    The method is carried out as follows.
    The polyanions that can be used in the proposed method are compounds comprising natural or synthetic polymers, such as polysaccharides or polystyrene, containing numerous anionic groups, such as sulfonic anions or carboxyl anions, and these compounds must be soluble in the reaction medium used for the antigen-antibody reaction.
    Such polyanions are dextro sulfate, heparin, polystyrene sulfate, cellulose acetate phthalate, hyaluronic acid, chondroitin sulfate, and the like.
    In accordance with the method of the invention, a sample containing a detectable antigen or antibody is treated with a polyanion, after which the antigen-antibody is reacted with the corresponding antibody or antigen in the reaction medium.
    The polyanion treatment can be carried out as follows: wire the antigen-antibody reaction in a medium that includes the polyanion, ipn treating the sample with a solid liquid with a polyannon-containing liquid phase, prior to the antigen-antibody reaction (in the latter case, the sample treated with antigen or An antibody can be antipassed to a reaction after the polyanion is removed from it, but usually it is introduced into the reaction together with the polyanion).
    Reaction media suitable for use in an antigen-antibody reaction are aqueous g (L).
    SP Sl
    four
    oo yu

    cm
    for example, saline solution and buffer solutions, which may contain one or more additives selected from stabilizers, preservatives, chelating agents, surfactants, etc.
    The buffer solution includes glycine buffers, phosphoric acid based buffers, citrate buffers, barbital buffers, borate buffers, buffers based on the tris (tris) hydroxymethyl (aminomethane) system — hydrochloric acid, tris-malate buffers, ammonium buffers, and t. d.
    Stabilizers include, for example, amino acids, polypeptides, proteins, and the like, which are not deposited in a given immunological reaction and which are usually present in a concentration of 0.001-1%, preferably from 0.05-0.6%.
    Preferred preservatives are merthiolate and sodium azide.
    Preferred chelating agents include ethylenediaminetetraacetic acid, nitrile triacetic acid, cyclohexandnamine tetraacetic acid, and the like.
    As a surfactant, it is generally preferred to use non-ionic surfactants.
    The pH of the reaction medium should be in the usual pH range, the dL of the antigen-antibody reactions used, typically using a pH in the range of about 5-10.
    The concentration of the polyanion in the reaction medium usually does not exceed 5 wt.% And preferably is equal to 0.001-0.5 wt.%.
    Higher concentrations can lead to instability in some assay systems. At the same time, more & less concentration reduces the inhibition of the so-called non-specific reactions that interfere with the analysis and make it impossible to obtain accurate data analysis due to the increased inhibitory effect.
    Antigens that serve as a detectable compound and reagent include various antigens, such as proteins, polypeptides, steroids, polysaccharides, lipids, pollen, dust and haptens. Antibodies include, for example, proteins that are
    pb-e are antibodies against these antigens.
    An antigen-antibody reaction assay according to the invention is applicable to any assay system. Thus, the proposed method is applicable both to solution systems, in which both the specific compound and the reagent are soluble in the reaction medium, and to systems with a carrier, in which the reagent is fixed on a special carrier that is practically insoluble in the reaction medium, with This suggests that the particular bed is sensitized with a reagent. Specific examples of antigen-antibody reactions that can be analyzed in accordance with the method of the invention include the regimens occurring during radioimmunoassay, when analyzing latex agglutination with turbidimetry in the near infrared region, enzyme-linked immunosorbent assay, immunofluorescence assay, with no.
    5 munonephelometry using light scattering, with erythrocyte agglutination, latex agglutination, etc. The method is particularly preferably used for an assay system such as agglutination of a latex with turbidimetry in the near PC region, in which, for example, reversible passive agglutination can be used. In accordance with the method of the invention, non-specific reactions that can occur during antigen-antibody reactions can be prevented, resulting in more accurate analysis data.
    PRI me R 1. Agglutination of latex with turbidimetry in the far infrared region.
    50 µl of a solution containing 1 µg / mm AFP and then 100 µl saline solution of bovine serum albumin containing dextran sulfate is added to 50 µl of normal human serum containing not more than 2 ng / ml of ф-fetoprotein (AFP) and then 100 µl of saline solution of bovine serum albumin containing dextran sulfate, and receive the test - solution. 50 µl of latex reagent sensitized with anti-AFP antibody and 200 µl of buffer solution are added to 50 µl of the test solution, after which, while stirring, some measured turbidity in the near-IR region at 940 nm is measured. The sample analysis data is read from the standard curve and the yield calculated. Results compared
    35
    40
    45
    50
    515547826
    with a control that represents the process, the method of soil
    reaction system without polyanion. increase the accuracy of analysis in 4-5 rl-e
    When adding dextran sulfate compared with the known method.
    (at the resulting concentration, the Formula of the invention is 0.001% by weight) the ena-Method for determining antigens or
    a significant improvement in accuracy (P antibodies by adding 0, 0t in the study) and coefficient of variation (KB), the sample of the corresponding special Normal deviation is 2.83% of the antibody or antigen with (by a known method 10.32) .JQ by following the registration of the passive hemagglutination reaction, The difference is that the procedure is applied with the fact that, for the purpose of raising t, the procedure is repeated, except for the accuracy of the method, the final concentration of the decomposition under study is treated with dextran sulfate,
    country sulfate is 5% by weight. f5 containing in the reaction medium in
    Similar results were obtained. Concentration 0.001-5.0 wt.%;
    权利要求:
    Claims (1)
    [1]
    SUMMARY OF THE INVENTION A method for determining antigens or antibodies by adding an appropriate specific antibody or antigen to a test sample, followed by recording a passive hemagglutination reaction, characterized in that, in order to improve the accuracy of the method, the test sample is treated with dextransulfate contained in the reaction medium at a concentration of 0.001-5, 0 wt.%;
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1554782A3|1990-03-30|Method of determining antigens or antibodies
    Branch et al.1982|A new reagent | having multiple applications in immunohematology
    CA1139203A|1983-01-11|Method and reagent for counteracting lipemicinterference
    US4578361A|1986-03-25|Creatinine antibody
    US4536478A|1985-08-20|Method for reducing non-specific interferences in agglutination immunoassays
    US4166106A|1979-08-28|Immunologic determination method
    JPH0664060B2|1994-08-22|Analyte detection method and detection agent
    US4052504A|1977-10-04|Assay for thyroxine binding globulin
    US6210975B1|2001-04-03|Process for determining a bindable analyte via immune precipitation and reagent therefor
    US4046870A|1977-09-06|Assay for free thyroid hormones
    CN101446586A|2009-06-03|Immunological assay reagents and assay method
    EP0064275B1|1985-08-21|Immunochemical reagent
    JPH0677019B2|1994-09-28|Enzyme-labeled antibody stabilization method
    JP3558645B2|2004-08-25|Use of polyclonal human anti-hTg autoantibodies as clinical diagnostics for thyroid autoimmune diseases and additives for the detection of anti-hTg autoantibodies in patient sera
    US4786591A|1988-11-22|Process for determining the binding capacity of thyroxin-binding globulin
    JP2994739B2|1999-12-27|Rapid measurement of trace components
    US4467030A|1984-08-21|Determination of the thyroxine-binding index in serum
    US3781414A|1973-12-25|Orgotein-polystyrene latex diagnostic for rheumatoid factor
    EP0253270B1|1992-09-23|Method for diagnostic immunoassay by solid phase separation
    JP2534067B2|1996-09-11|Quantitative method for C-reactive protein
    JP2589088B2|1997-03-12|Determination of anti-streptolysin O
    PrIce et al.1981|Kinetic immunoturbidimetry of human choriomammotropin in serum.
    AU667700B2|1996-04-04|Method for determining rheumatoid factors and agents for carrying out the method
    Gartner et al.1991|A Microparticle Enhanced Nephelometric Immunoassay | Applied to Thymulin Measurement
    Van Blerk et al.1996|Four radioisotopic immunoassays of free thyroxine compared
    同族专利:
    公开号 | 公开日
    PT74835B|1983-10-28|
    CA1195925A|1985-10-29|
    CS257757B2|1988-06-15|
    CS312182A2|1987-09-17|
    JPS57182169A|1982-11-09|
    PT74835A|1982-05-01|
    AU8282382A|1982-07-01|
    IL65767A|1985-06-30|
    US4672045A|1987-06-09|
    NO821444L|1982-11-03|
    EP0064274A1|1982-11-10|
    ES511797A0|1983-02-01|
    KR880001533B1|1988-08-19|
    DE3262469D1|1985-04-04|
    AT12010T|1985-03-15|
    NO159820B|1988-10-31|
    DK158481C|1990-10-08|
    DK158481B|1990-05-21|
    HU188057B|1986-03-28|
    AU559966B2|1987-03-26|
    KR830010384A|1983-12-30|
    EP0064274B1|1985-02-27|
    ES8302313A1|1983-02-01|
    ZA822726B|1983-11-30|
    JPS6367864B2|1988-12-27|
    NO159820C|1989-02-08|
    DD202178A5|1983-08-31|
    DK190682A|1982-11-03|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US4148869A|1975-03-06|1979-04-10|Baxter Travenol Laboratories, Inc.|Immunological reagent and method of using same|
    US4162192A|1978-09-28|1979-07-24|Juridical Foundation|Method for purification of HBs antigen|
    US4223005A|1979-02-15|1980-09-16|University Of Illinois Foundation|Antibody coated bacteria|JPS61241665A|1985-04-18|1986-10-27|Toyobo Co Ltd|Stabilized sold phase reagent|
    US5459078A|1988-01-29|1995-10-17|Abbott Laboratories|Methods and reagents for performing ion-capture digoxin assays|
    US5459080A|1988-01-29|1995-10-17|Abbott Laboratories|Ion-capture assays using a specific binding member conjugated to carboxymethylamylose|
    US5866322A|1988-01-29|1999-02-02|Abbott Laboratories|Method for performing Rubella assay|
    US5141853A|1988-07-22|1992-08-25|Abbott Laboratories|Determination of ammonia levels in a sample|
    JPH0750110B2|1988-12-22|1995-05-31|積水化学工業株式会社|Immunoassay|
    JPH0750108B2|1988-12-26|1995-05-31|積水化学工業株式会社|Immunoreactivity assay|
    CA2109924A1|1991-05-30|1992-12-10|Janina Adamczyk|Reagents containing a nonspecific binding blocker in ion-capture binding assays|
    DE4328684A1|1993-08-26|1995-03-02|Boehringer Mannheim Gmbh|Method for determining an analyte according to the agglutination principle|
    US5486479A|1994-05-02|1996-01-23|Mitsubishi Chemical Corporation|Buffer for immunoassay, kit including same and immunoassay method using said buffer|
    JP2003066047A|2001-06-14|2003-03-05|Matsushita Electric Ind Co Ltd|Immune reaction measuring method and immune reaction measuring reagent used therefor|
    DE60225788T2|2001-12-27|2008-07-17|Matsushita Electric Industrial Co., Ltd., Kadoma|IMMUNO REACTION MEASUREMENT PROCEDURE FOR IMMUNE REACTION MEASUREMENT|
    KR20050083623A|2002-12-10|2005-08-26|마쯔시다덴기산교 가부시키가이샤|Immunoreaction measurement method|
    EP1610128B8|2003-03-31|2007-10-03|DENKA SEIKEN Co., Ltd.|TURBIDIMETRIC IMMUNOASSAY FORLIPOPROTEINAND REAGENT THEREFOR|
    JP4580180B2|2004-02-26|2010-11-10|デンカ生研株式会社|Measurement value decrease inhibitor for immunoassay and immunoassay using the same|
    JP5238190B2|2007-05-24|2013-07-17|株式会社ビーエル|Immunoassay in the presence of hyaluronic acid and products used therefor|
    JP2010127827A|2008-11-28|2010-06-10|Abbott Japan Co Ltd|Nonspecific interaction inhibitor, and its application to diagnostic measuring system|
    JP5535601B2|2009-12-01|2014-07-02|デンカ生研株式会社|Measurement value decrease inhibitor for immunoassay and immunoassay using the same|
    JP6116268B2|2013-01-31|2017-04-19|デンカ生研株式会社|Methods for suppressing false negatives in biological mucosa-derived specimen measurement immunoassays|
    JP6675834B2|2015-05-21|2020-04-08|デンカ生研株式会社|Immunochromatographic test strip and immunochromatographic method using the same|
    JP6651794B2|2015-11-05|2020-02-19|富士レビオ株式会社|Cardiac troponin I measuring reagent and method|
    WO2017179611A1|2016-04-13|2017-10-19|株式会社Ｌｓｉメディエンス|Immunoassay employing sulfated polysaccharide|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP56067333A|JPS6367864B2|1981-05-02|1981-05-02|
    [返回顶部]